
Novartis has sealed an agreement with Cadent Therapeutics to acquire the firm in a deal worth up to $770 million, …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

